LQZ-7F

Overview

LQZ-7F, a survivin dimerization inhibitor, induces spontaneous apoptosis and synergizes with Docetaxel in prostate cancer cells. LQZ-7F dose-dependently inhibits survival of both PC-3 and C4-2 cells with IC 50 s of 2.99 and 2.47 µM, respectively.

Application

Products | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Survivin | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-122678
• CAS No.: 354543-09-2
• Molecular Formula: C14H7N9O3
• Molecular Weight: 349.26
• Purity: 97.44%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 10 mg/mL (28.63 mM); Suspended solution; Need ultrasonic and warming and heat to 60°C
• Availability: In-stock

Source

Original product source